Board-certified anesthesiologist Elliott Bennett-Guerrero serves Duke University as professor of anesthesiology, a position he has held since 2008. During his ongoing tenure as director of perioperative clinical research with the Duke Clinical Research Institute, in 2010 Elliott-Bennett Guerrero facilitated clinical trials on the application of gentamicin-collagen sponges onto surgical sites, the results of which were published in the New England Journal of Medicine.
There is interest in potentially using topical antibiotics to reduce the risk of surgical wound infection. Topical or local use implies that the antibiotic is administered at the site of the wound and not systemically as through an intravenous (IV) catheter or through the mouth, ie gastrointestinal tract. A potential benefit of topical antibiotics is to maintain low levels of drug in the bloodstream despite the high concentration of antibiotic around the site of application. This is important since high levels of some antibiotics in the bloodstream can be harmful, for example to the kidneys. Currently there are no FDA-approved, topically-applied antibiotics for the prevention of surgical site infection after abdominal surgery.
0 Comments
|
AuthorDr. Elliott Bennett-Guerrero is both an educator and a vice chairman at Stony Brook Medicine. Archives
June 2022
Categories
All
|